...
首页> 外文期刊>American journal of engineering and applied sciences >Cross Validation Evaluation for Breast Cancer Prediction Using Multilayer Perceptron Neural Networks | Science Publications
【24h】

Cross Validation Evaluation for Breast Cancer Prediction Using Multilayer Perceptron Neural Networks | Science Publications

机译:多层感知器神经网络对乳腺癌预测的交叉验证评估科学出版物

获取原文

摘要

> Problem statement: The presence of metastasis in the regional lymph nodes is the most important factor in predicting prognosis in breast cancer. Many biomarkers have been identified that appear to relate to the aggressive behaviour of cancer. However, the nonlinear relation of these markers to nodal status and also the existence of complex interaction between markers have prohibited an accurate prognosis. Approach: The aim of this study is to investigate the effectiveness of a Multilayer Perceptron (MLP) for predicting breast cancer progression using a set of four biomarkers of breast tumors. The biomarkers include DNA ploidy, cell cycle distribution (G0G1/G2M), steroid receptors (ER/PR) and S-Phase Fraction (SPF). A further objective of the study is to explore the predictive potential of these markers in defining the state of nodal involvement in breast cancer. Two methods of outcome evaluation viz. stratified and simple k-fold Cross Validation (CV) are studied in order to assess their accuracy and reliability for neural network validation. Criteria such as output accuracy, sensitivity and specificity are used for selecting the best validation technique besides evaluating the network outcome for different combinations of markers. Results: The results show that stratified 2-fold CV is more accurate and reliable compared to simple k-fold CV as it obtains a higher accuracy and specificity and also provides a more stable network validation in terms of sensitivity. Best prediction results are obtained by using an individual marker-SPF which obtains an accuracy of 65%. Conclusion/Recommendations: Our findings suggest that MLP-based analysis provides an accurate and reliable platform for breast cancer prediction given that an appropriate design and validation method is employed.
机译: > 问题陈述:区域淋巴结转移的存在是预测乳腺癌预后的最重要因素。已经鉴定出许多与癌症的攻击行为有关的生物标志物。然而,这些标志物与淋巴结状态之间的非线性关系以及标志物之间复杂相互作用的存在阻碍了准确的预后。 方法:这项研究的目的是使用一组四种乳腺癌生物标记物,研究多层感知器(MLP)预测乳腺癌进展的有效性。生物标记包括DNA倍性,细胞周期分布(G0G1 / G2M),类固醇受体(ER / PR)和S相组分(SPF)。该研究的另一个目标是探索这些标志物在确定淋巴结受累状态方面的预测潜力。结果评估的两种方法。为了评估神经网络验证的准确性和可靠性,研究了分层和简单的k倍交叉验证(CV)。除了评估不同标记组合的网络结果外,还使用诸如输出准确性,敏感性和特异性之类的标准来选择最佳验证技术。 结果:结果表明,与简单的k倍CV相比,分层2倍CV更准确和可靠,因为它具有更高的准确性和特异性,并且在敏感性方面也提供了更稳定的网络验证。最好的预测结果是通过使用单个标记SPF获得的,该标记SPF的准确度达到65%。 结论/建议:我们的发现表明,只要采用适当的设计和验证方法,基于MLP的分析就可以为乳腺癌的预测提供准确而可靠的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号